ArticleJournal of cellular and molecular medicine2025
Identification of Biomarkers and Immune-Metabolic Regulators in Acute Pancreatitis and Sarcopenia: A Multi-Modal Transcriptomics Study.
Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rev-erb-α in Skeletal Muscle Adaptation: Integrating Circadian Control Mechanisms and Exercise Dynamic Responses.Journal of cellular physiology · 2026Review
- Identification of Biomarkers and Immune-Metabolic Regulators in Acute Pancreatitis and Sarcopenia: A Multi-Modal Transcriptomics Study.Journal of cellular and molecular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Studies suggest a clinically significant association between acute pancreatitis and sarcopenia. However, the molecular mechanisms behind this association have not been fully elucidated. Here, we systematically investigated gene expression profiles by differentially expressed gene (DEG) analysis, weighted gene co-expression network analysis (WGCNA) and functional enrichment analysis, and identified a total of 36 genes as shared genes between acute pancreatitis and sarcopenia. Functional enrichment analysis revealed that these genes were enriched in immune-inflammatory processes and pathways. Furthermore, we evaluated relevant hub genes in a random forest model and investigated their expression, diagnostic performance and immune cell relationships. Random forest modelling prioritised chloride intracellular channel 5 (CLIC5), solute carrier family 38 member 1 (SLC38A1) and complement C1q B chain (C1QB) as key candidate biomarkers. Immune infiltration analysis linked these genes to dysregulated T cells, monocytes and mast cells in both diseases. Finally, we constructed a regulatory network involving miRNAs, mRNAs and transcription factors to illustrate further the regulations of three genes' transcription in acute pancreatitis and sarcopenia. The diagnostic value of CLIC5, SLC38A1 and C1QB was performed by receiver operating characteristic curves and the area under the curve in the datasets, and the validation results confirmed a consistent trend of downregulation of CLIC5 and SLC38A1 in AP and sarcopenia. This study revealed for the first time that CLIC5 and SLC38A1 were shared biomarkers for AP and sarcopenia. Their association with immune-metabolic dysregulation highlights their potential as therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.